Wondfo USA
Wondfo USA manufactures point-of-care rapid diagnostic tests — including COVID-19/Flu A&B multiplex, toxicology, harm reduction, women's fertility, and veterinary assays — serving consumers, healthcare providers, employers, and veterinarians across the US and Canada.
- Company typePrivate
- Founded2009
- HeadquartersBolingbrook, United States
- Headcount—
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Wondfo USA does
Wondfo USA Co. Ltd. is a privately held manufacturer of point-of-care diagnostic tests, founded in 2009 and headquartered in Bolingbrook, IL, with a research and production center in San Diego, CA and a dedicated Canadian distribution facility. The company sells lateral-flow immunochromatographic assays and one immunofluorescence instrument (PETlife Pro-DX) across four branded sub-portfolios: WELLlife (infectious disease, including FDA 510(k)-cleared and EUA-authorized COVID-19, Influenza A&B, and multiplex COVID/Flu tests, plus Strep A and iFOB colorectal screening), SAFElife (urine, oral-fluid, and hair toxicology plus fentanyl, xylazine, and benzodiazepine harm-reduction test strips), HORMONElife and BABYlife (pregnancy, ovulation, FSH, and PdG testing paired with a fertility-prediction mobile app), and PETlife (canine/feline progesterone, T4, and pancreatic lipase testing with a companion breeder app). Core technology is conventional rapid lateral-flow chemistry with sub-brand-specific assay formulations achieving claimed accuracies of >95% to >99% against gold-standard LC-MS/MS comparators; no AI-native capabilities are disclosed beyond simple probability modeling in the HORMONElife app.
Wondfo USA firmographics
Firmographics- Name
- Wondfo USA
- Legal name
- WONDFO USA CO., LTD.
- Website
- https://wondfousa.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Short description
- Wondfo USA manufactures point-of-care rapid diagnostic tests — including COVID-19/Flu A&B multiplex, toxicology, harm reduction, women's fertility, and veterinary assays — serving consumers, healthcare providers, employers, and veterinarians across the US and Canada.
- Ownership category
- akta.pro rank
Where Wondfo USA is headquartered
LocationHeadquarters
- HQ city
- Bolingbrook
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Wondfo USA business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Rapid Diagnostic Test Products: One-time purchase model for point-of-care diagnostic test kits across infectious disease, toxicology, women's health, and veterinary categories. Revenue from product sales through direct channels, distributors, and retail partners.
- Instrument/Analyzer Sales: Sale of diagnostic instruments including PETlife Pro-DX Immunofluorescence Analyzer for veterinary diagnostics. No contract tie-in, pay-per-test model.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Product pricing varies by product category and configuration |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels6 records
Wondfo USA product offering
Product offeringCore offering
Wondfo USA manufactures and distributes rapid point-of-care diagnostic test kits and benchtop analyzers across four divisions: WELLlife (infectious disease such as COVID-19, influenza A&B, strep A, fecal occult blood), SAFElife (drugs of abuse screening in urine, oral fluid, hair, and surface samples), HORMONElife and BABYlife (women's reproductive health strips), and PETlife (veterinary diagnostics run on the Pro-DX immunofluorescence analyzer). The company sells through direct sales, authorized distributors, retailers, and a Canadian distribution center to both professional healthcare customers and at-home consumers.
Product overview
Wondfo USA is a leading manufacturer of point-of-care rapid diagnostic tests organized into four main product sub-brands: WELLlife (infectious disease testing), SAFElife (toxicology/drug testing), HORMONElife/BABYlife (women's health and fertility), and PETlife (veterinary diagnostics). The WELLlife portfolio includes FDA 510(k) cleared and EUA-authorized COVID-19/Influenza A&B multiplex tests, standalone COVID-19 antigen tests, Flu A&B tests, iFOB fecal occult blood tests for colorectal cancer screening, and Strep A tests. SAFElife offers comprehensive toxicology solutions including multi-drug urine test cups and dip cards, oral fluid tests for cotinine and alcohol, hair follicle tests for long-term drug detection (90 days), and harm reduction test strips for fentanyl, xylazine, and benzodiazepines in liquid/powder samples. HORMONElife and BABYlife provide pregnancy tests, ovulation predictor kits, FSH tests, and a companion mobile app with predictive analytics for fertility tracking. PETlife features a portable immunofluorescence analyzer (Pro-DX) for canine progesterone, T4 thyroid, and pancreatic lipase testing, paired with the Pup Planner mobile app for breeders.
Differentiator
Problem solved
Functional benefit
Brands
- WELLlife: Rapid point-of-care and OTC testing products for infectious diseases including COVID-19, influenza, and iFOB tests for health providers and consumers.
- SAFElife
- HORMONElife
- PETlife
- BABYlife
Products and services
- WELLlife COVID-19 Antigen Test
- WELLlife COVID-19 / Influenza A&B Antigen Test
- WELLlife Influenza A&B Test
- WELLlife iFOB Fecal Occult Blood Test
- WELLlife Strep A Test
- SAFElife Multi-Drug Urine Test Cup
- SAFElife T-Dip Multi-Drug Urine Dip Card
- SAFElife Fentanyl Urine Test
- SAFElife T-Swab Cotinine and Alcohol Oral Fluid Test
- SAFElife Hair Processor and Multi-Panel Rapid Hair Test
- SAFElife Fentanyl Liquid and Powder Test Strip
- SAFElife Xylazine Liquid and Powder Test Strip
- SAFElife Benzodiazepines Liquid and Powder Test
- HORMONElife Pregnancy Test
- HORMONElife Ovulation Test Strip
- HORMONElife PdG Urine Test Strip
- HORMONElife Ultra Accurate FSH Test Strip
- BABYlife Pregnancy Test
- PETlife Pro-DX Immunofluorescence Analyzer
Quantifiable outcome
- COVID-19 Antigen Test: Over 99% accuracy for negative tests, Over 84% accuracy for positive tests
- +4 more outcomes
Companies that use Wondfo USA
Customer profileSegments4 records
Ideal customer profiles4 records
Wondfo USA technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature5 records
Wondfo USA partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- DCN DxcoreCollaboration with DCN Dx, a leading contract research organization for in vitro diagnostics, through the NIH Rapid Acceleration of Diagnostics (RADx) Tech program for the development of WELLlife COVID-19/Influenza A&B test. DCN Dx provides research and validation services ensuring highest quality, accuracy, and reliability.
- National Institutes of Health (NIH) RADx Tech ProgramcoreNIH RADx Tech program supporting rapid development and validation of COVID-19/Influenza diagnostic tests. Provides funding, expertise, and validation infrastructure for accelerated FDA clearance.
- Fact.MRminorMarket research firm providing industry analysis on pet at-home diagnostics market. Wondfo USA identified as one of 15-20 active players in market projected to reach USD 150.65 million by 2036.
- Omega Laboratories, Inc.coreComparative evaluation partner for SAFElife Multi-Panel Rapid Hair Test. Omega Laboratories conducted independent validation comparing Wondfo's hair test against their gold standard LC-MS/MS methodology.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Wondfo USA competitors and assessment
Company assessmentBroad incumbents
- Abbott (Diagnostics): Global diagnostics leader with BinaxNOW rapid COVID/Flu and Strep tests, plus broader IVD and lab-testing franchises. Competes with Wondfo across rapid respiratory testing categories but at materially greater scale and brand recognition.
- Becton, Dickinson and Company (BD): Operates the BD Veritor rapid-testing system for Flu, COVID and Strep A used in physician offices and urgent care, alongside women's health and drug-testing products. A broad incumbent overlapping directly with WELLlife and SAFElife.
- IDEXX Laboratories: Global leader in veterinary diagnostics with in-clinic analyzers and rapid test kits for companion and livestock animals. Overlaps with Wondfo's PETlife Pro-DX analyzer at a much larger installed base, particularly in fertility, thyroid and pancreatic testing.
- Zoetis: Largest pure-play animal health company with diagnostics, vaccines, and point-of-care vet testing. Competes with Wondfo PETlife in the broader vet diagnostics market but offers a much wider portfolio beyond diagnostics.
Direct peers
- QuidelOrtho Corporation: Major US manufacturer of rapid IVD tests including COVID-19, Influenza A/B and Strep A assays used in both clinical point-of-care and OTC channels. Highly comparable product portfolio, channels, and regulatory posture to Wondfo's WELLlife line.
- ACON Laboratories: US-headquartered rapid diagnostic manufacturer with lateral-flow COVID, Flu, pregnancy, fertility and drug-of-abuse tests sold OTC and to clinical channels. Closely comparable product mix and channel strategy to Wondfo across all four sub-brands.
- BTNX Inc. Canadian rapid IVD manufacturer with strong HIV, pregnancy, drug-of-abuse and infectious disease lateral-flow products. Direct peer in both product categories and North American distribution footprint overlapping with Wondfo's Canadian channel.
- SPD Swiss Precision Diagnostics (Clearblue): Global leader in home pregnancy and ovulation testing under the Clearblue brand, with connected fertility tracking. Directly comparable to Wondfo's HORMONElife/BABYlife lines at a much larger consumer brand scale.
- Premier Biotech: US-based drug-testing and toxicology product manufacturer offering urine drug test cups, dip cards, oral fluid and saliva-based tests. Direct overlap with Wondfo's SAFElife multi-drug, fentanyl and harm-reduction product lines.
- Princeton BioMeditech Corporation: Developer and manufacturer of rapid immunoassay tests for pregnancy, ovulation, drugs of abuse, infectious disease and cardiac markers. Closely comparable rapid-test product mix and lateral-flow technology base to Wondfo's HORMONElife, SAFElife and WELLlife lines.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Wondfo USA social profiles
Digital presenceWondfo USA compliance and trust
Trust signalCompliance13 records
Wondfo USA financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wondfo USA leadership team
Management profileNumber of profiles
Profiles2 records
Wondfo USA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wondfo USA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wondfo USA
What does Wondfo USA do?
Wondfo USA manufactures and distributes rapid point-of-care diagnostic test kits and benchtop analyzers across four divisions: WELLlife (infectious disease such as COVID-19, influenza A&B, strep A, fecal occult blood), SAFElife (drugs of abuse screening in urine, oral fluid, hair, and surface samples), HORMONElife and BABYlife (women's reproductive health strips), and PETlife (veterinary diagnostics run on the Pro-DX immunofluorescence analyzer). The company sells through direct sales, authorized distributors, retailers, and a Canadian distribution center to both professional healthcare customers and at-home consumers.
Is Wondfo USA a public or private company?
Wondfo USA is a private company. It is classified as unknown and is currently operating.
When was Wondfo USA founded?
Wondfo USA was founded in 2009.
Where is Wondfo USA based?
Wondfo USA is headquartered in Bolingbrook, United States, in the North America region.
How does Wondfo USA make money?
Two revenue lines are on record. Rapid Diagnostic Test Products are the primary driver. The others are instrument/Analyzer Sales.
Who are Wondfo USA's main competitors?
Broad incumbents on record are Abbott (Diagnostics), Becton, Dickinson and Company (BD), IDEXX Laboratories and Zoetis. Direct peers are QuidelOrtho Corporation, ACON Laboratories, BTNX Inc., SPD Swiss Precision Diagnostics (Clearblue), Premier Biotech and Princeton BioMeditech Corporation.
Does Wondfo USA have an API?
No public API is recorded for Wondfo USA.